Sellas Ebit from 2010 to 2024

SLS Stock  USD 1.17  0.05  4.10%   
Sellas Life EBIT yearly trend continues to be comparatively stable with very little volatility. EBIT will likely drop to about -39.2 M in 2024. From the period from 2010 to 2024, Sellas Life EBIT quarterly data regression had r-value of (0.23) and coefficient of variation of (66.13). View All Fundamentals
 
EBIT  
First Reported
2007-03-31
Previous Quarter
-19.3 M
Current Value
-15.2 M
Quarterly Volatility
7.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sellas Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sellas Life's main balance sheet or income statement drivers, such as Interest Expense of 806.9 K, Other Operating Expenses of 28.8 M or Research Development of 16.3 M, as well as many indicators such as Price To Sales Ratio of 60.05, Dividend Yield of 0.037 or Days Sales Outstanding of 78.69. Sellas financial statements analysis is a perfect complement when working with Sellas Life Valuation or Volatility modules.
  
Check out the analysis of Sellas Life Correlation against competitors.

Latest Sellas Life's Ebit Growth Pattern

Below is the plot of the Ebit of Sellas Life Sciences over the last few years. It is Sellas Life's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sellas Life's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Pretty Stable
   Ebit   
       Timeline  

Sellas Ebit Regression Statistics

Arithmetic Mean(28,511,733)
Geometric Mean23,453,080
Coefficient Of Variation(66.13)
Mean Deviation13,650,818
Median(30,059,000)
Standard Deviation18,855,612
Sample Variance355.5T
Range76M
R-Value(0.23)
Mean Square Error362.5T
R-Squared0.05
Significance0.41
Slope(971,693)
Total Sum of Squares4977.5T

Sellas Ebit History

2024-39.2 M
2023-37.3 M
2022-32.4 M
2021-20.9 M
2020-16.8 M
2019-20 M
2018-35.7 M

Other Fundumenentals of Sellas Life Sciences

About Sellas Life Financial Statements

Sellas Life shareholders use historical fundamental indicators, such as Ebit, to determine how well the company is positioned to perform in the future. Although Sellas Life investors may analyze each financial statement separately, they are all interrelated. The changes in Sellas Life's assets and liabilities, for example, are also reflected in the revenues and expenses on on Sellas Life's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EBIT-37.3 M-39.2 M
EBITDA529 K555.5 K
Ebt Per Ebit 0.99  1.10 
Ebit Per Revenue(48.24)(45.83)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.